183 related articles for article (PubMed ID: 33165772)
1. Seroprevalence of Neutralizing Antibodies against Six Human Adenovirus Types Indicates the Low Level of Herd Immunity in Young Children from Guangzhou, China.
Tian X; Fan Y; Wang C; Liu Z; Liu W; Xu Y; Mo C; You A; Li X; Rong X; Zhou R
Virol Sin; 2021 Jun; 36(3):373-381. PubMed ID: 33165772
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China.
Zheng X; Rong X; Feng Y; Sun X; Li L; Wang Q; Wang M; Liu W; Li C; Yang Y; Zhou R; Lu J; Feng L; Chen L
Emerg Microbes Infect; 2017 Jun; 6(6):e43. PubMed ID: 28588291
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
Wang X; Kerkmann L; Hetzel M; Windmann S; Trilling M; Zhang W; Ehrhardt A; Bayer W
J Virol; 2022 Nov; 96(22):e0113322. PubMed ID: 36342295
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China.
Yi H; Wang Q; Deng J; Li H; Zhang Y; Chen Z; Ji T; Liu W; Zheng X; Ma Q; Sun X; Zhang Y; Yu X; He M; Chen L; Feng Y
Virol Sin; 2022 Oct; 37(5):716-723. PubMed ID: 35764207
[TBL] [Abstract][Full Text] [Related]
5. Seroepidemiological investigation of HAdV-4 infection among healthy adults in China and in Sierra Leone, West Africa.
Wang B; Li J; Wu S; Chen Y; Zhang Z; Zhai Y; Guo Q; Zhang J; Song X; Zhao Z; Hou L; Chen W
Emerg Microbes Infect; 2018 Dec; 7(1):200. PubMed ID: 30514848
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Patients with Neuromuscular Disorders.
Klann PJ; Wang X; Elfert A; Zhang W; Köhler C; Güttsches AK; Jacobsen F; Weyen U; Roos A; Ehrke-Schulz E; Ehrhardt A; Vorgerd M; Bayer W
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680119
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of neutralizing antibodies to human mastadenovirus serotypes 3 and 7 in healthy children from guangdong province.
Kuang L; Wang C; Chen H; Li Y; Liang Z; Xu T; Guo M; Zhu B
Heliyon; 2023 Jun; 9(6):e16986. PubMed ID: 37346335
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions.
Yang WX; Zou XH; Jiang SY; Lu NN; Han M; Zhao JH; Guo XJ; Zhao SC; Lu ZZ
Vaccine; 2016 Nov; 34(46):5579-5586. PubMed ID: 27682509
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of human adenovirus type 5 neutralizing antibodies in the Philippines.
Francisco AG; Reyes JCB; Tabios IKB; Cruz CJG; Ang MAC; Heralde FM; Lacuna ARG; de Paz-Silava SLM
PLoS One; 2023; 18(12):e0293046. PubMed ID: 38039314
[TBL] [Abstract][Full Text] [Related]
10. Molecular typing of human adenoviruses among hospitalized patients with respiratory tract infections in a tertiary Hospital in Guangzhou, China between 2017 and 2019.
Wang X; Wang D; Umar S; Qin S; Ling Q; Gray GC; Liu Y
BMC Infect Dis; 2021 Aug; 21(1):748. PubMed ID: 34344310
[TBL] [Abstract][Full Text] [Related]
11. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R
Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605
[TBL] [Abstract][Full Text] [Related]
12. A review of 65 years of human adenovirus seroprevalence.
Mennechet FJD; Paris O; Ouoba AR; Salazar Arenas S; Sirima SB; Takoudjou Dzomo GR; Diarra A; Traore IT; Kania D; Eichholz K; Weaver EA; Tuaillon E; Kremer EJ
Expert Rev Vaccines; 2019 Jun; 18(6):597-613. PubMed ID: 31132024
[No Abstract] [Full Text] [Related]
13. Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.
Haque E; Banik U; Monowar T; Anthony L; Adhikary AK
PLoS One; 2018; 13(3):e0194516. PubMed ID: 29590206
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China.
Yu B; Zhou Y; Wu H; Wang Z; Zhan Y; Feng X; Geng R; Wu Y; Kong W; Yu X
J Med Virol; 2012 Sep; 84(9):1408-14. PubMed ID: 22825819
[TBL] [Abstract][Full Text] [Related]
16. Molecular Identification and Epidemiological Features of Human Adenoviruses Associated with Acute Respiratory Infections in Hospitalized Children in Southern China, 2012-2013.
Chen Y; Liu F; Wang C; Zhao M; Deng L; Zhong J; Zhang Y; Ye J; Jing S; Cheng Z; Guan Y; Ma Y; Sun Y; Zhu B; Zhang Q
PLoS One; 2016; 11(5):e0155412. PubMed ID: 27171486
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients.
Zhao H; Xu C; Luo X; Wei F; Wang N; Shi H; Ren X
Front Immunol; 2018; 9():335. PubMed ID: 29563911
[TBL] [Abstract][Full Text] [Related]
18. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.
Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R
J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776
[TBL] [Abstract][Full Text] [Related]
19. Detection of enteric- and non-enteric adenoviruses in gastroenteritis patients, Bangladesh, 2012-2015.
Afrad MH; Avzun T; Haque J; Haque W; Hossain ME; Rahman AR; Ahmed S; Faruque ASG; Rahman MZ; Rahman M
J Med Virol; 2018 Apr; 90(4):677-684. PubMed ID: 29244212
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.
Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
